Chan, A; Vanlemmens, L; Conte, PF; Beith, J; Samonigg, H; Verma, S; Srimuninnimit, V; Martoni, A; Miles, DW.
Efficacy of bevacizumab (BV) plus docetaxel (D) does not correlate with hypertension (HTN) or G-CSF use in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) in the AVAIDO phase III study
CANCER RES. 2009; 69(2):114S-114S.-31st Annual San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, TX.
[Poster]
Web of Science